Skip to main content

Advertisement

SpringerLink
Log in

Adiponectin Induces Breast Cancer Cell Migration and Growth Factor Expression

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Adiponectin, the hormone produced and secreted by adipocytes, has been shown to promote migration of the epithelial cells and angiogenesis in these cells. We sought to determine if adiponectin could induce the cellular migration and growth factor expression in breast cancer cells grown in vitro. The breast cancer cell lines MDA-MB-436 and MFM-223 (estrogen-independent) were treated with adiponectin for different time periods. Supernatants of the cell cultures were obtained by centrifugation and were assayed for growth factor expression by the enzyme-linked immunosorbent assay (ELISA). Becton–Dickinson-Falcon Transwell systems were used to assay adiponectin-induced migration. Adiponectin significantly induced the expression of various growth factors, including vascular endothelial growth factor, transforming growth factor-β1, and basic fibroblast growth factor in MDA-MB-436 and MFM-223 cells. Adiponectin also enhanced the migration of breast cancer cells which were inhibited about 50–70 % by the inhibitors of mitogen-activated protein kinase and phosphatidylinositol 3-kinase (PI3K). Adiponectin treatment of the cancer cell induced an increased expression of different growth factors and migration of the cells. These effects are likely to contribute to the progression of breast cancer, implying that change in adiponectin levels associated with obesity may be considered as a high risk factor in breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. van Kruijsdijk, R., van der Wall, E., & Visseren, F. (2009). Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiology, Biomarkers and Prevention, 18(10), 2569–2578.

    Article  PubMed  Google Scholar 

  2. Schlienger, J. L., et al. (2009). Obesity and cancer. Revue de Medecine Interne, 30(9), 776–782.

    Article  PubMed  Google Scholar 

  3. Calle, E. E., et al. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine, 348(17), 1625–1638.

    Article  PubMed  Google Scholar 

  4. Neugut, A. I., Chen, A. C., & Petrylak, D. P. (2004). The “skinny” on obesity and prostate cancer prognosis. Journal of Clinical Oncology, 22(3), 395–398.

    Article  PubMed  Google Scholar 

  5. Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012). The role of adiponectin in cancer: A review of current evidence. Endocrine Reviews, 33(4), 547–594.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Kelesidis, I., Kelesidis, T., & Mantzoros, C. (2006). Adiponectin and cancer: A systematic review. British Journal of Cancer, 94(9), 1221–1225.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Tian, Y. F., et al. (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocrine-Related Cancer, 14(3), 669–677.

    Article  PubMed  CAS  Google Scholar 

  8. Cnop, M., et al. (2003). Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46, 459–469.

    PubMed  CAS  Google Scholar 

  9. Perrier, S., & Jarde, T. (2012). Adiponectin, an anti-carcinogenic hormone? A systematic review on breast, colorectal, liver and prostate cancer. Current Medicinal Chemistry, 19(32), 5501–5512.

    Article  PubMed  CAS  Google Scholar 

  10. Wu, M. H., et al. (2009). Circulating levels of leptin, adiposity and breast cancer risk. British Journal of Cancer, 100(4), 578–582.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Sun, C. A., et al. (2010). Adipocytokine resisting and breast cancer risk. Breast Cancer Research and Treatment, 123(3), 869–876.

    Article  PubMed  CAS  Google Scholar 

  12. Grossmann, M. E., et al. (2008). Balance of adiponectin and leptin modulates breast cancer cell growth. Cell Research, 18(11), 1154–115625.

    Article  PubMed  CAS  Google Scholar 

  13. Prieto-Hontoria, P. L., et al. (2011). Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochimica Et Biophysica Acta-Bioenergetics, 1807(6SI), 664–678.

    Article  CAS  Google Scholar 

  14. Zhang, X. T., et al. (2012). Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells. PLoS One, 7(1), e30174. doi:10.1371/journal.pone.0030174.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Grossmann, M. E., et al. (2008). Effects of adiponectin on breast cancer cell growth and signaling. British Journal of Cancer, 98, p370–p379.

    Article  Google Scholar 

  16. Körner, A., et al. (2007). Total and high molecular weight adiponectin in breast cancer: In vitro and in vivo studies. J Clin Endocrinol & Metabolism, 92(3), 1041–1048.

    Article  Google Scholar 

  17. Lijnen, H. R., & Scroyen, I. (2013). Effect of vascular endothelial growth factor receptor 2 antagonism on adiposity in obese mice. Journal of Molecular Endocrinology, 50(3), 319–324.

    Article  PubMed  CAS  Google Scholar 

  18. Moon, H. S., et al. (2013). Salutary effects of adiponectin on colon cancer: In vivo and in vitro studies in mice. Gut, 62(4), 561–570.

    Article  PubMed  CAS  Google Scholar 

  19. Hu, D., et al. (2013). Adiponectin regulates vascular endothelial growth factor-C expression in macrophages via Syk-ERK pathway. PLOS One, 8, e560712.

    Article  Google Scholar 

  20. Fayad, R., et al. (2007). Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology, 132(2), 601–614.

    Article  PubMed  CAS  Google Scholar 

  21. Du, B. W., et al. (2013). The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-beta (TGF beta) signaling. Journal of Biological Chemistry, 288(5), 3036–3047.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Wanninger, J., et al. (2011). Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes. FEBS Letters, 585(9), 1338–1344.

    Article  PubMed  CAS  Google Scholar 

  23. Masuda, H., et al. (2012). Role of Epidermal Growth Factor Receptor in Breast Cancer. Breast Cancer Research and Treatment,. doi:10.1007/s10549-012-2289-9.

    PubMed Central  Google Scholar 

  24. Miyoshi, Y., et al. (2003). Association of serum adiponectin levels with breast cancer risk. Clinical Cancer Research, 9, 5699–5704.

    PubMed  CAS  Google Scholar 

  25. Hou, W. K., et al. (2007). Adipocytokines and breast cancer risk. Chinese Medical Journal (English Edition), 120, 1592–1596.

    CAS  Google Scholar 

  26. Kang, J. H., et al. (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. Journal of Korean Medical Science, 22, 117–121. doi:10.3346/jkms.2007.22.1.117.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  27. Mantzoros, C., et al. (2004). Adiponectin and breast cancer risk. Journal of Clinical Endocrinology and Metabolism, 89, 1102–1107. doi:10.1210/jc.2003-031804.

    Article  PubMed  CAS  Google Scholar 

  28. Tworoger, S. S., et al. (2007). Plasma adiponectin concentrations and risk of incident breast cancer. Journal of Clinical Endocrinology and Metabolism, 92, 1510–1516. doi:10.1210/jc.2006-1975.

    Article  PubMed  CAS  Google Scholar 

  29. Gaudet, M. M., et al. (2010). Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women. Cancer Epidemiology, 34, 580–586. doi:10.1016/j.canep.2010.05.014.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  30. Miyatani, Y., et al. (2008). Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause, 15, 536–541. doi:10.1097/gme.0b013e31815c85ed.

    Article  PubMed  Google Scholar 

  31. Liu, L.-Y., et al. (2013). The role of adiponectin in breast cancer: A meta-analysis. PloS One, 8(8), e73183. doi:10.1371/journal.pone.0073183.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thyroid and Breast Surgery, Affiliated Hospital of Binzhou Medical College, Binzhou, 256610, People’s Republic of China

    Zhongming Jia

  2. Department of Gynecology, Binzhou People’s Hospital, Binzhou, 256610, People’s Republic of China

    Yan Liu

  3. Department of General Emergency Surgery, Affiliated Hospital of Binzhou Medical College, Binzhou, 256610, People’s Republic of China

    Shouyong Cui

Authors
  1. Zhongming Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shouyong Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhongming Jia.

Additional information

Zhongming Jia and Yan Liu equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jia, Z., Liu, Y. & Cui, S. Adiponectin Induces Breast Cancer Cell Migration and Growth Factor Expression. Cell Biochem Biophys 70, 1239–1245 (2014). https://doi.org/10.1007/s12013-014-0047-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0047-9

Keywords

Search

Navigation